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Background. Stroke aetiologymay affect the risk and causes of readmission after ischaemic stroke (IS) and transient ischaemic attack
(TIA) due to differences in risk factors, functional outcome, and treatment. We aimed to examine frequencies, causes, and risk of
30-day readmission by stroke subtype, determine predictors of 30-day readmission, and study the impact of 30-day readmissions
on one-year mortality. Methods. All surviving patients admitted with IS or TIA from July 2007 to December 2013 were followed
by review of medical records for all unplanned readmissions within 30 days after discharge. Stroke subtype was classified as large-
artery atherosclerosis (LAA), cardioembolism (CE), small vessel occlusion (SVO), stroke of other determined aetiology (SOE),
or stroke of undetermined aetiology (SUE). Cox regression analyses were performed to assess the risk of 30-day readmission for
the stroke subtypes and identify predictors of 30-day readmission, and its impact on one-year mortality. Results. Of 1874 patients,
200 (10.7%) were readmitted within 30 days [LAA 42/244 (17.2%), CE 75/605 (12.4%), SVO 12/205 (5.9%), SOE 6/32 (18.8%), SUE
65/788 (8.3%)]. The most frequent causes of readmissions were stroke-related event, infection, recurrent stroke/ TIA, and cardiac
disease. After adjusting for age, sex, functional outcome, length of stay, and the risk factor burden, patients with LAA and SOE
subtype had significantly higher risks of readmission for any cause, recurrent stroke or TIA, and stroke-related events. Predictors
of 30-day readmission were higher age, peripheral arterial disease, enteral feeding, and LAA subtype. Thirty-day readmission was
an independent predictor of one-year mortality. Conclusions. Patients with LAA or SOE have a high risk of 30-day readmission,
possibly caused by an increased risk of recurrent stroke and stroke-related events. Awareness of the risk of readmission for different
causes and appropriate handling according to stroke subtype may be useful for preventing some readmissions after stroke.
1. Introduction
Stroke treatment has improved considerably over the last
decades, but 30-day readmission rates after stroke have
remained unchanged in Norway [1]. Thirty-day readmission
rates range from 6.0% to 15.0%, with infections, recur-
rent stroke, and cardiac conditions as leading causes [1–
8]. Reducing 30-day readmission is an important target in
reducing post-stroke morbidity, mortality, and health care
costs [9]. Many studies have attempted to identify predictors
of readmission after stroke as this might help detect high-risk
patients, but results across studies are inconsistent [2]. Factors
previously associatedwith 30-day readmission include higher
age, functional status, prior stroke or cardiac disease, longer
hospitalisation, and complications during stroke admission
[2–4].
Aetiologies causing ischaemic stroke (IS) and tran-
sient ischaemic attack (TIA) are categorised into different
stroke subtypes [10]. Cardiovascular risk factors, neurological
deficits, functional outcome, and early recurrence differ
between the subtypes [11–13]; therefore, stroke subtype may
influence the rates and causes of 30-day readmission. In
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lack of existing prediction models on the risk of 30-day
readmission after stroke, estimating the risk of readmission
for the different stroke subtypes might be a valuable approach
for detecting patients at higher risk of readmission. This
would also be easily accessible in a clinical setting. However,
the impact of stroke subtype on 30-day readmission risk is
not clear.
The aims of our study were to examine (1) frequency,
causes, and risk of 30-day readmission for the stroke sub-
types, (2) factors associated with unplanned readmission
within 30 days, and (3) the impact of 30-day readmission on
one-year mortality.
2. Methods
All patients with IS or TIA admitted to the Stroke Unit
at the Department of Neurology, Haukeland University
Hospital, from July 2007 to December 2013, were prospec-
tively registered in the Bergen NORSTROKE Registry. The
Stroke Unit serves a well-defined geographical area with
approximately 275,000 inhabitants. Patients with residence
outside the geographic area of the hospital at the time of
index hospitalisation were excluded from the study to ensure
complete follow-up after discharge.
IS was defined as an episode of neurologic deficit lasting
>24 hours because of ischaemic lesions or transient ischaemic
attacks where computed tomography or magnetic resonance
imaging showed infarctions related to the clinical findings
[14]. TIA was a clinical diagnosis defined as transient focal
cerebral dysfunction lasting < 24 hours with no objective
evidence of brain infarction on imaging. Electrocardiogram,
echocardiography, and duplex ultrasound of the carotid
arteries were obtained during hospital admission. Stroke
aetiology was classified by a stroke neurologist (HN) accord-
ing to the Trial of Org 10172 in Acute Stroke Treatment
(TOAST) criteria as large-artery atherosclerosis (LAA), car-
dioembolism (CE), small vessel occlusion (SVO), stroke of
other determined aetiology (SOE), or stroke of undetermined
aetiology (SUE) [10]. The National Institutes of Health
Stroke Scale (NIHSS) was used to assess stroke severity on
admission and day 7, or at discharge if earlier. Short-term
functional outcome was determined by modified Rankin
Scale (mRS) and Barthel Index (BI) on day 7 or at discharge
if earlier. Clinical characteristics, treatment, medical history,
comorbidity, complications, and the discharge destination
were registered before discharge from the Stroke Unit. The
number of traditional cardiovascular risk factors was defined
as the risk factor burden (0, 1, 2, or ≥ 3). These included
hypertension, diabetes mellitus, smoking, angina pectoris,
peripheral arterial disease, and prior myocardial infarction.
Secondary prevention from the day of discharge was based
on the Norwegian guidelines for stroke treatment [15].
Two clinicians (ATB & ANK) collected information
on readmission and death by reviewing electronic medical
records from all ten hospitals within the region of the
Western Norway Regional Health Authorities. Readmission
was defined as an unplanned admission to any department at
any of the hospitals within the region of the Western Norway
Regional Health Authorities. All unplanned readmissions
within 30 days after discharge were registered and divided
into predefined categories (any cause, recurrent stroke,
stroke-related event, seizure, infection, cardiac disease, frac-
ture, venous thromboembolism, gastrointestinal haemor-
rhage, and other cause). Only the first readmission within
each category was registered for each patient. Patients who
died during index hospitalisation and patients discharged to
palliative care were excluded from the analyses.
The study was approved by the Western Regional Ethics
Committee, andwritten informed consent was obtained from
all patients or their legal guardian.
Statistical analyses were performed using Stata 14.0 (Stata
Corporation, College Station, TX, USA). Baseline charac-
teristics were assessed by chi-squared test, Student’s t-test,
Mann–Whitney’s U-test, or Kruskal-Wallis H-test as appro-
priate.The risks of readmission for any cause and for themost
common categories of readmission were assessed by Cox
regression analyses for each subtype compared to patients
with other stroke subtypes. In addition to the stroke subtype,
all analyses included age, sex, mRS score, length of stay, and
the risk factor burden to adjust for potential confounding
factors. Predictors of the 30-day readmission were assessed
by Cox regression with stepwise backward elimination of all
significant parameters (P<.05) from the univariate analyses.
Age, sex, mRS score, and length of stay were forced into
the multivariate analyses to adjust for potential confounding
factors. The impact of 30-day readmission on one-year
mortality was studied by Cox regression analyses adjusted
for age, sex, mRS score, and risk factors for cerebrovascular
disease and death, after excluding patients who died within
30 days after discharge.
3. Results
A total of 1989 patients were admitted to the stroke unit and
diagnosedwith IS (89.6%) or TIA (10.4%), of whom 101 (5.1%)
died in the stroke unit, and 14 (0.7%) were discharged to
palliative care. The final study population consisted of 1874
patients, of whom 200 (10.7%) were readmitted within 30
days (10.9% of IS patients, 9.2% of TIA patients, p = 0.475).
The distribution of readmissions among the stroke subtypes
was as follows: LAA 42/244 (17.2%), CE 75/605 (12.4%), SVO
12/205 (5.9%), SOE 6/32 (18.8%), and SUE 65/788 (8.3%).
Nineteen patients had two unplanned readmissions within
30 days, and two patients had three unplanned readmissions
within 30 days. Median time to first unplanned readmission
was 11 days (IQR 5-19).
Baseline characteristics of the study population by 30-
day readmission status are presented in Table 1. Patients who
were readmitted within 30 days were in general older, had
a poorer short-term functional outcome (higher mRS score
and lower BI score), and a higher NIHSS score at discharge
than patients not readmitted within 30 days. Readmitted
patients also had more cardiovascular comorbidity and a
higher risk factor burden, and more frequently experienced
complications during the index hospitalisation than patients
not readmitted within 30 days. Patients with LAA subtype
weremore likely to be readmitted, whereas patients with SVO
or SUE subtype were less likely to be readmitted.
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N = 1674 P
Age (years), mean ± SD 77.2 ± 11.8 72.8 ± 13.7 <0.001
Male sex 105 (52.5) 931 (55.6) 0.402
Stroke severity and functional outcome
mRS score at discharge, median (IQR) 2 (1, 4) 2 (1, 3) <0.001
NIHSS score at discharge, median (IQR) 3 (1, 8) 1 (0, 4) <0.001
BI score at discharge, median (IQR) 90 (40, 100) 100 (75, 100) <0.001
Stroke subtype
Atherosclerosis 42 (21.0) 202 (12.1) <0.001
Cardioembolism 75 (37.5) 530 (31.7) 0.095
Small vessel occlusion 12 (6.0) 193 (11.5) 0.018
Other determined aetiology 6 (3.0) 26 (1.6) 0.136
Undetermined aetiology 65 (32.5) 723 (43.2) 0.004
Comorbidities
Prior stroke 49 (24.5) 324 (19.4) 0.085
Peripheral arterial disease 26 (13.0) 110 (6.6) 0.001
Diabetes 39 (19.5) 244 (14.6) 0.066
Angina pectoris 40 (20.0) 220 (13.1) 0.008
Myocardial infarction 35 (17.5) 235 (14.0) 0.188
Hypertension 133 (66.5) 922 (55.1) 0.002
Atrial fibrillation 70 (35.0) 475 (28.4) 0.051
Prior/current smoking 122 (61.0) 965 (57.7) 0.364
Risk factor burden 0.007
0 44 (22.0) 463 (27.7)
1 66 (33.0) 643 (38.4)
2 53 (26.5) 377 (22.5)
≥3 37 (18.5) 191 (11.4)
Treatment
Intravenous thrombolysis 33 (16.5) 274 (16.4) 0.962
Thrombectomy 6 (3.0) 22 (1.3) 0.063
Complications during the stroke hospitalisation
Urinary tract infection 38 (19.0) 187 (11.2) 0.001
Incontinence 31 (15.5) 211 (12.6) 0.248
Urinary retention 55 (27.5) 325 (19.4) 0.007
Pneumonia 24 (12.0) 105 (6.3) 0.002
Enteral feeding 29 (14.5) 106 (6.3) <0.001
Seizures 9 (4.5) 36 (2.2) 0.040
Stroke in progression 23 (11.5) 147 (8.8) 0.206
Any complication 100 (50.0) 637 (38.1) 0.001
Length of stay, median (IQR) 6 (3, 11) 6 (3, 10) 0.553
Discharged destination
Home 77 (38.5) 928 (56.0) <0.001
Home nursing 28 (14.0) 166 (10.0) 0.081
Rehabilitation department 10 (5.0) 141 (8.5) 0.087
Nursing home 69 (34.5) 376 (22.7) <0.001
Other department 16 (8.0) 47 (2.8) <0.001
SD: standard deviation, mRS: modified Rankin Scale, IQR: interquartile range, NIHSS: National Institutes of Health Stroke Scale, BI: Barthel Index.
Data are expressed as n (%) unless specified.
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Table 2: Causes of unplanned readmissions within 30 days after IS or TIA by stroke subtype.











Any cause 200 (10.7) 42 (17.2) 75 (12.4) 12 (5.9) 6 (18.8) 65 (8.3) <0.001
Recurrent stroke 34 (1.8) 11 (4.5) 8 (1.3) 1 (0.5) 3 (9.4) 11 (1.4) <0.001
IS 26 (1.4) 6 (2.5) 7 (1.2) 1 (0.5) 3 (9.4) 9 (1.1) 0.001
TIA 4 (0.2) 4 (1.6) 0 0 0 0 <0.001
ICH 4 (0.2) 1 (0.4) 1 (0.2) 0 0 2 (0.3) 0.898
Stroke-related event 51 (2.7) 16 (6.6) 11 (1.8) 4 (2.0) 3 (9.4) 17 (2.2) <0.001
Seizures 5 (0.3) 0 3 (0.5) 0 0 2 (0.3) 0.647
Infections 37 (2.0) 7 (2.9) 13 (2.2) 4 (2.0) 0 13 (1.7) 0.703
Pneumonia 19 (1.0) 3 (1.2) 6 (1.0) 3 (1.5) 0 7 (0.9) 0.913
UTI 9 (0.5) 1 (0.4) 4 (0.7) 0 0 4 (0.5) 0.810
Sepsis 5 (0.3) 2 (0.8) 1 (0.2) 1 (0.5) 0 1 (0.1) 0.395
Other 4 (0.2) 1 (0.4) 2 (0.3) 0 0 1 (0.1) 0.806
Cardiac disease 26 (1.4) 1 (0.4) 17 (2.8) 0 0 8 (1.0) 0.005
MI 6 (0.3) 0 1 (0.2) 0 0 5 (0.6) 0.350
Arrhythmias 5 (0.3) 1 (0.4) 4 (0.7) 0 0 0 0.167
Other 16 (0.9) 0 13 (2.2) 0 0 3 (0.4) 0.001
Fractures 7 (0.4) 0 5 (0.8) 0 0 2 (0.3) 0.244
VT 3 (0.2) 1 (0.4) 1 (0.2) 0 0 1 (0.1) 0.846
GI bleeding 4 (0.2) 0 2 (0.3) 1 (0.5) 0 1 (0.1) 0.739
Other causes 49 (2.6) 13 (5.3) 20 (3.3) 3 (1.5) 0 13 (1.7) 0.011
IS: ischaemic stroke, TIA: transient ischaemic attack, LAA: large artery atherosclerosis, CE: cardioembolism, SVO: small vessel occlusion, SOE: stroke of other
determined aetiology, SUE: stroke of undetermined aetiology, ICH: intracerebral haemorrhage, UTI: urinary tract infection, MI: myocardial infarction, VT:
venous thromboembolism, GI: gastrointestinal.
Data are presented as n (%). Only the first readmission within each category is counted.











Age (years), median (IQR) 75 (66, 82) 79 (68, 86) 69 (60, 80) 47 (38, 56) 74 (64, 83) <0.001
Male sex, N (%) 159 (65.2) 318 (52.6) 123 (60.0) 21 (65.6) 415 (52.7) 0.002
mRS score, median (IQR) 2 (0, 3) 2 (1, 4) 2 (1, 3) 1 (0, 2) 1 (0, 3) <0.001
Length of stay (days) 5 (3, 9) 6 (3, 10) 6 (3, 10) 8 (5, 12) 6 (3, 9) 0.029
Risk factor burden, N (%) <0.001
0 34 (13.9) 168 (27.8) 55 (26.8) 15 (46.9) 235 (29.8)
1 83 (34.0) 234 (38.7) 86 (42.0) 17 (53.1) 289 (36.7)
2 70 (28.7) 142 (23.5) 42 (20.5) 0 (0.0) 176 (22.3)
≥3 57 (23.4) 61 (10.1) 22 (10.7) 0 (0.0) 88 (11.2)
IQR: interquartile range, mRS: modified Rankin Scale.
The most frequent cause of readmission was stroke-
related events: 10 with evolving strokes (NIHSS score wors-
ening ≤ 4 points from NIHSS score at discharge with
symptoms from the same vascular territory as the index
stroke), 19 with aggravation of existing neurological deficits
(neurological symptomsnotmeasurable by theNIHSS score),
2 with haemorrhagic transformation, 3 with neurological
complications after carotid endarterectomy, 1 with extracra-
nial haemorrhage, 1 with carotid dissection, and 15 with other
neurological symptoms. The length of index hospitalisation
was slightly shorter for patients that were readmitted with
a stroke-related event compared to patients that were not
readmitted with a stroke-related event (median 5 days (IQR
5-8) versus median 6 days (IQR 3-10), p=0.193). Infection
was the second most frequent cause of readmission, followed
by recurrent stroke or TIA, and cardiac disease. The causes
of readmission were unevenly distributed among the stroke
subtypes (Table 2).
Table 3 shows the distribution of age, sex, mRS score,
length of stay, and the risk factor burden among the stroke
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Table 4: Factors Associated with 30-day Unplanned Readmission
after IS or TIA.
Hazard
Ratio 95% Confidence Interval P
Age (years) 1.020 1.006 – 1.034 0.004
Sex (male) 0.936 0.690 – 1.268 0.667
mRS score 0.990 0.894 – 1.095 0.842
Length of stay (days) 0.997 0.973 – 1.022 0.846
Peripheral arterial
disease 1.577 1.007 – 2.468 0.047
LAA subtype 1.735 1.201 – 2.505 0.003
Enteral feeding 1.861 1.112 – 3.114 0.018
IS: ischaemic stroke, TIA: transient ischaemic attack, mRS: modified Rankin
Scale, LAA: large artery atherosclerosis.
subtypes. After adjusting for these factors, patients with
stroke due to LAA had an increased risk of readmission for
any cause (HR=1.76, 95%CI 1.22-2.53, p=0.002), readmission
with recurrent stroke or TIA (HR = 3.31, 95% CI 1.55-
7.07, p=0.002), and readmission with stroke-related events
(HR=2.98, 95%CI 1.55-5.74, p=0.001). Patients with SOE had
an increased risk of readmission for any cause (HR=2.81,
95% CI 1.11-7.10, p=0.029), recurrent stroke (HR=6.00, 95%
CI 1.26-28.57, p=0.024), and stroke-related events (HR=4.27,
95% CI 1.19-15.35, p=0.026). The recurrent strokes in the
SOE group were ascribed to dissection of the middle cere-
bral artery, giant cerebral aneurysm, and pancreatic cancer,
respectively. Patients with SUE had a lower risk of readmis-
sion for any cause compared to other subtypes (HR=0.71,
95% CI 0.52-0.97, p=0.031). Patients with CE subtype had
an increased risk of readmission due to cardiac disease
(HR=2.56, 95% CI 1.07-6.09, p=0.034). Exclusion of SOE
from the regression models did not alter any findings.
Factors independently associated with 30-day readmis-
sion from the final Cox regression model were increasing
age, history of peripheral arterial disease, enteral feeding dur-
ing index hospitalisation (nasogastric tube or percutaneous
endoscopic gastrostomy), and LAA subtype (Table 4).
Within 30 days, 61 (3.3%) patients died, of whom 29
(47.5%) had been readmitted. There were no significant dif-
ferences in 30-day mortality between stroke subtypes (LAA
3.3%, CE 4.1%, SVO 1%, SOE 0%, and SUE 3.3%, p = 0.203).
Within one year, 139 (7.4%) additional patients died, of whom
36 (25.9%) had been readmitted within 30 days. One-year
mortality significantly differed between the stroke subtypes
(LAA 11.8%, CE 14.0%, SVO 3.4%, SOE 3.1%, and SUE 10.2%,
p = 0.001).Thirty-day readmission significantly increased the
risk of one-year mortality in patients surviving 30 days after
discharge after adjusting for age, sex, mRS score, and risk
factors for cerebrovascular disease and death (HR 2.57, 95%
CI 1.75 – 3.78, p < 0.001).
4. Discussion
This is one of the first and the current largest studies inves-
tigating the impact of stroke subtype on 30-day readmission
after ischaemic stroke or TIA. Our study demonstrates that
30-day readmission varies depending on the stroke subtype,
ranging from 5.9% for patients with SVO to 17.2% for
patients with LAA and 18.8% for patients with SOE. A study
performed in a younger stroke population found that 14%
of patients with thrombotic strokes were readmitted within
30 days, whereas 22% of patients with CE strokes were
readmitted within 30 days [16]. Another study found that
22% of patients with CE and 20% of patients with LAA
subtypewere readmittedwithin 30 days, whereas SUEhad the
lowest rate of readmission, with 8% readmittedwithin 30 days
[4]. These discrepancies are likely due to study populations
with different demography, lower mean ages, and different
distribution of stroke subtypes than ours.
The varying readmission rates between the stroke sub-
types could be caused by differences in age, functional
outcome, and risk factors. After adjusting for these factors,
patients with SVO, which had the lowest number of read-
mission, did not have a lower risk of readmission compared
to other subtypes. However, the risk of 30-day readmission
was significantly increased in patients with LAA and SOE
subtype, whereas patients with SUE had a significantly lower
risk of readmission after adjusting for confounders.
Two of the most common causes of readmission were
stroke-related events and recurrent stroke. The risk of recur-
rent stroke is highest in the early phase after the initial
IS or TIA [11]. Awareness and attention towards recurrent
strokes and a low threshold for readmission in cases which
could represent recurrent strokes, may contribute to a high
rate of readmissions with stroke-related events such as
aggravation or fluctuation of existing neurologic symptoms.
Thus, education of patients and their families in the natural
course of the post-stroke period may reduce some of these
readmissions.
In concordance with recent studies on 30-day recurrence,
only 1.8 % were readmitted with a recurrent stroke within
30 days [17, 18]. However, 4.5% of patients with LAA
subtype were readmitted with recurrent stroke within 30
days. LAA subtype has previously been associated with early
recurrent stroke [11, 12]. This could be caused by repetitive
shedding of thrombi from unstable atherosclerotic plaques
triggered by shear stress [19], or cerebral ischaemia induced
by carotid surgery in some patients, but the reason for the
high risk of early recurrence in patients with LAA is not
yet fully understood. Patients with LAA or SOE subtype
had increased risks of recurrent stroke and stroke-related
events, which likely explains their overall increased risk of
30-day readmission. LAA subtype was also an independent
predictor of 30-day readmission, probably due to increased
recurrence of recurrent stroke or TIA and aggravation of
neurological symptoms. Few studies have reported stroke
recurrence for patients with SOE as a result of low numbers
of subjects. The increased risk of recurrence as well as
readmission for any cause and stroke-related events for
patients with SOE in our study could be a chance finding
due to a low number of subjects and should be interpreted
with caution. However, it is possible that SOE includes
some rare aetiologies with an especially high risk of early
recurrence.
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Infection was a frequent complication during index hos-
pitalisation in our study, and the second most common cause
of readmission. Early infections after stroke are associated
with enteral feeding whichmight explain why enteral feeding
independently increased the risk of 30-day readmission [20].
Poor functional outcome has also been associated with post-
stroke infections [21]. Even though there were differences in
short-term functional outcome between the stroke subtypes,
the median mRS score was 2 or less for all stroke subtypes.
This might explain why we found no differences in infection-
related readmission between the stroke subtypes. Poor func-
tional outcome and length of stay have been associated with
early readmission [2, 3]. This could be due to an increased
risk of infection in patients with poor functional outcome
as well as a higher risk of undetected medical complications
if patients are discharged too early [21]. The present study
unexpectedly found that poor functional outcome and length
of stay were not associated with readmission. This could
be due to higher rates of cardiovascular and stroke-related
readmissions than infections, which, in contrast to infections,
likely are not affected by functional outcome or length of
stay to the same extent. This might also explain why we
found no differences in readmission between IS and TIA
patients.
Thirty-day readmission was significantly associated with
an increased risk of one-year mortality. This has previ-
ously been demonstrated [9] and could perhaps be due
to interference with functional recovery after stroke if
the patient is readmitted. Also, the cause of readmission
might contribute to a worse prognosis and higher post-
stroke mortality, as demonstrated for post-stroke pneumonia
and recurrent stroke [22, 23]. Even though most readmis-
sions are unavoidable when reviewed retrospectively [24],
a reduction in readmission rates have been demonstrated
with early outpatient visits by physicians, and with edu-
cation of patients about relevant diagnoses, and confir-
mation of the medication plan [25–27]. Sufficient moni-
toring and care for prevention of medical complications,
both during hospitalisation and in the immediate post-
hospital care setting, may be key factors in preventing
some readmissions. In addition, a thorough evaluation for
detecting the underlying cause of the stroke and awareness
of readmission risk and treatment according to the stroke
subtype may be useful in preventing some readmissions after
stroke.
A weakness of the present study is the lack of information
in the few cases where patients were transferred to other
hospital departments. It is unlikely that we have missed some
readmissions, as we exclusively included patients served by
our hospital and obtained data on readmissions from all ten
hospitals in our region. Our study is unable to demonstrate
a direct, causative relationship between stroke subtype and
readmissions as it was an observational study. The study-
design limits the generalisability due to possible selection
bias, but it provides precise and verified clinical data with the
use of a comprehensive registry and medical record review,
contributing to a better understanding of underlying causes
of the readmissions.
5. Conclusions
Readmission within 30 days after IS and TIA remains fre-
quent in Norway. The risk and causes of 30-day readmission
differed between the stroke subtypes and were especially
high in patients with LAA and SOE. Stroke subtype may
substitute as a 30-day readmission risk estimator in lack of
more precise risk-estimation models, but more studies are
needed to confirm our findings.
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